Shelter Pharma Ltd

Shelter Pharma Ltd has announced the launch of its new Ayurvedic Herbal Human Healthcare product, SHELTIDIN DS – Cough Spray. This herbal throat-soothing spray is designed for fast relief from dry cough, sore throat, and irritation. The product is now available on e-commerce platforms, with the launch date officially stated as August 20th, 2026. Developed by the company's in-house R&D team, the product currently caters to the domestic market, with potential future exploration of international markets. This launch aligns with Shelter Pharma's commitment to innovation and its long-term growth strategy, leveraging its over 60 years of experience in the pharmaceutical industry and GMP-approved manufacturing facilities.

Shelter Pharma Ltd has announced the successful completion and dispatch of an export order valued at USD 12,285 to Genet International in Bangladesh. The order includes veterinary products such as Feedmin Bolus, Regulin Bolus, Lactocal Gel, and Buta-B Bolus. The company confirmed that the full amount has been settled and the goods have been dispatched. This achievement marks a significant milestone for Shelter Pharma, highlighting its growing international presence and commitment to delivering quality products. The company attributes this success to its state-of-the-art manufacturing facilities and the dedication of its team, reinforcing its reputation in the pharmaceutical and nutraceutical industry.

Shelter Pharma Ltd has announced the successful completion of manufacturing and dispatch of an export order for All Vitamins Tablets to Taha Drugs & Chemicals Co. Ltd. The order, valued at USD 103,538, has been fully settled and dispatched to Sudan. This marks a significant milestone for the company, highlighting its expanding global presence and commitment to delivering quality products on time. The successful execution reinforces Shelter Pharma's capabilities and its position in the pharmaceutical and nutraceutical industry, driven by its advanced facilities and expert team.

Shelter Pharma Ltd announced the appointment of Ms. Vinita Shivraj Gadhvi as an Additional Independent Director to its Board. The appointment, effective July 31, 2026, is for a term of five consecutive years, subject to shareholder approval. Ms. Gadhvi is an accomplished entrepreneur and healthcare professional with over 12 years of experience in pharmaceuticals and healthcare innovation. She is not related to any existing directors or key managerial personnel and is not debarred from holding a director's office. Her appointment aligns with Sections 149, 152, and 161(1) of the Companies Act, 2013, based on the Nomination and Remuneration Committee's recommendation.

Shelter Pharma Ltd announced the appointment of Ms. Vinita Shivraj Gadhvi as an Additional Independent Director for a five-year term, effective July 31, 2026. Her appointment is subject to shareholder approval. The Board also reconstituted the CSR Committee, with Ms. Gadhvi joining as a member. The meeting, held on July 31, 2026, also covered other board-level discussions. Ms. Gadhvi brings over 12 years of experience in pharmaceuticals and healthcare, with a strong background in quality assurance, regulatory compliance, and business development.

Shelter Pharma Ltd has announced the receipt of significant international purchase orders from Genet International. These orders are for the supply of Veterinary Feed Supplements, including FEEDMIN BOLUS, REGULIN BOLUS, Lactocal Gel, and BUTA-B BOLUS. The total value of these orders amounts to USD 12,285. The company views this as a major milestone, expecting it to bolster its export business, enhance its global presence, and contribute positively to revenue growth and overall business expansion. The transactions are conducted in the normal course of business and do not involve promoters or related parties.

Shelter Pharma Ltd has received a work order from Verka Dairy Ludhiana for the supply of Veterinary Feed Supplements. The order includes DIA-VET BLOUS and For retention of Placenta/Ecbloic (UTRON) products, with a total value of INR 50,347.50. This domestic order, awarded in the normal course of business, reflects Verka Dairy's confidence in Shelter Pharma's capabilities and commitment to quality. The company expects this order to contribute positively to its future revenues and profitability.

Shelter Pharma Ltd has announced the receipt of significant international purchase orders from Al-Saqr Agro for Agricultural and Veterinary Entries. The orders are for Veterinary Feed Supplements, including Multina Liquid and Super Vitamas, with a total value of USD 27,664. The terms include 100% advance payment, CNF pricing, and a 2-month delivery timeline from payment. This development is seen as a milestone for the company, reflecting its growing acceptance in international markets and is expected to contribute positively to its revenue and business expansion. The promoter group has no interest in the ordering entity, and the transaction is at arm's length.

Shelter Pharma Ltd has announced the successful completion and dispatch of an export order valued at USD 18,300. The order was received on March 12, 2026, from First Veterinary Medicines Trading LLC, UAE, for Animal Healthcare products. The company views this as a significant milestone, reflecting its expanding global reach and commitment to timely delivery of quality products. The entire order value has been manufactured and dispatched.

Shelter Pharma Ltd has issued a corrigendum to its earlier intimation regarding the H2 FY2026 Investor Conference Call. The correction addresses a typographical error in the day of the week for the call, which was incorrectly stated as Wednesday, June 19, 2026. The company clarified that the correct day is Friday, June 19, 2026. All other details, including the date, time, meeting link, and meeting ID, remain unchanged. Shelter Pharma Ltd regrets any inconvenience caused by this error.